Abingdon, United Kingdom

Ronan Pádraic O'Dwyer

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ronan Pádraic O'Dwyer

Introduction

Ronan Pádraic O'Dwyer is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of immunotherapy, particularly through his work on T cell receptors. With a total of 3 patents to his name, O'Dwyer's innovations are paving the way for advancements in cancer treatment.

Latest Patents

O'Dwyer's latest patents focus on T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide SLLQHLIGL, derived from the germline cancer antigen PRAME. These TCRs may include non-natural mutations within the alpha and/or beta variable domains relative to a native PRAME TCR. The TCRs developed by O'Dwyer are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant diseases.

Career Highlights

O'Dwyer is currently associated with Immunocore Limited, a company that specializes in developing innovative therapies for cancer. His work has been instrumental in advancing the understanding and application of T cell receptors in immunotherapy.

Collaborations

Some of O'Dwyer's notable coworkers include Philip William Addis and Nicole Joy Bedke. Their collaborative efforts contribute to the ongoing research and development in the field of immunotherapy.

Conclusion

Ronan Pádraic O'Dwyer is a prominent figure in the realm of immunotherapy, with his innovative patents and contributions significantly impacting cancer treatment. His work continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…